Winterville, NC – April 3, 2024 — NantHealth, Inc. (NASDAQ-GS: NH), proudly announces the expansion of its product leadership team...
This infographic describes why there is a drug shortage, which drugs are impacted, and how Eviti Connect can help alleviate...
Explore our informative 3-part video series, delving into the messaging pillars of Eviti Connect for Oncology. Learn how payers can...
The financial impact of chronic disease in the U.S. is sobering. According to the Centers for Disease Control (CDC), 90%...
They’re often called the four “pillars” of cancer treatment because of their prevalence. Physicians have used surgery, chemotherapy, radiation therapy,...
Now that the Centers for Medicare & Medicaid Services (CMS) has lowered the boom on payers by dropping the star...
This white paper highlights 5 pressing challenges payers face as they attempt to enable the best outcomes for their members,...
As the biopharmaceutical industry evolves rapidly, biosimilar products are reshaping the autoimmune treatment paradigm. This comprehensive eBook explores the role...
Radiation therapy (RT) is one of several treatment types for cancer in both curative and palliative settings. It is used...
NantHealth explores the impact of new biosimilar drugs for autoimmune treatment. We will discuss how payers can prepare for the...
If a recent LinkedIn poll is any indication, managing high drug costs associated with cancer care continues to be a...
With many new emerging technologies in healthcare, we look at how these technologies impact patient-centric care. The Institute of Medicine defines patient-centric...